Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole

BACKGROUND: This study aims to compare the efficacy and safety between zoledronic acid combined with calcium and calcium alone to prevent aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole. METHODS: One hundred twenty patients were randoml...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Shengliang, Wang, Fuchao, Dou, Honglei, Zhang, Longqiang, Li, Jiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063560/
https://www.ncbi.nlm.nih.gov/pubmed/27785049
http://dx.doi.org/10.2147/OTT.S115058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063560/
https://www.ncbi.nlm.nih.gov/pubmed/27785049
http://dx.doi.org/10.2147/OTT.S115058

Ejemplares similares